Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...
To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...
The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....
Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...
North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...
Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...
Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...
The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...
Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...
Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...
In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...
China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...
China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...
Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top thr...
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...
